DIMA Biotech

DIMA Biotechnology is a leading biotech company specialising in preclinical research and development solutions for the biopharmaceutical industry. They offer a wide selection of pre-designed and validated antibody molecules for early-stage drug development, with over 5,000 lead antibodies targeting around 400 drug targets. Their focus is to develop antibodies for all potential drug targets, and advance antibody-based drug discovery through innovative platforms and cutting-edge technologies.

Additionally, DIMA also offer a wide range of high-quality proteins and assays to enable the the development of life-changing therapies.